ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 123 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $56,949,000 | -39.1% | 2,026,656 | 0.0% | 0.26% | -31.2% |
| Q1 2022 | $93,510,000 | -47.5% | 2,026,656 | -4.3% | 0.38% | -26.3% |
| Q4 2021 | $178,063,000 | +26.1% | 2,118,284 | 0.0% | 0.51% | +32.6% |
| Q3 2021 | $141,162,000 | +10.6% | 2,118,284 | -11.7% | 0.39% | 0.0% |
| Q2 2021 | $127,642,000 | +22.6% | 2,399,284 | 0.0% | 0.39% | +24.8% |
| Q1 2021 | $104,105,000 | -33.4% | 2,399,284 | -20.3% | 0.31% | -27.9% |
| Q4 2020 | $156,406,000 | +7.7% | 3,011,284 | -32.2% | 0.43% | -18.1% |
| Q3 2020 | $145,251,000 | -31.9% | 4,443,284 | 0.0% | 0.52% | -43.1% |
| Q2 2020 | $213,366,000 | – | 4,443,284 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |